UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 126

Sortiert nach

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

The lancet oncology, 2016-03, Vol.17 (3), p.367-377

2016

Link zum Volltext

Verfügbarkeit prüfen

Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer

Journal of clinical oncology, 2011-12, Vol.29 (34), p.4498-4504

2011

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial

JNCI : Journal of the National Cancer Institute, 2010-08, Vol.102 (16), p.1253-1262

2010

Link zum Volltext

Verfügbarkeit prüfen

Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

Breast cancer research and treatment, 2020-06, Vol.181 (2), p.347-359

2020

Link zum Volltext

Verfügbarkeit prüfen

Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial

Breast cancer research and treatment, 2021-02, Vol.185 (3), p.697-707

2021

Link zum Volltext

Verfügbarkeit prüfen

Bias in survival estimates created by a requirement for consent to enter a clinical breast cancer registry

Cancer epidemiology, 2019-02, Vol.58, p.178-183

2019

Link zum Volltext

Verfügbarkeit prüfen

CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1–98 trial

Breast cancer research and treatment, 2015-06, Vol.151 (2), p.373-384

2015

Link zum Volltext

Verfügbarkeit prüfen

Medical resource utilization for administration of trastuzumab in a New Zealand oncology outpatient setting: a time and motion study

ClinicoEconomics and outcomes research, 2015-01, Vol.7 (default), p.423-430

2015

Link zum Volltext

Verfügbarkeit prüfen

Overall survival from breast cancer in women pregnant or lactating at or after diagnosis

International journal of cancer, 1996-09, Vol.67 (6), p.751-755

1996

Link zum Volltext

Verfügbarkeit prüfen

A Durable Complete Remission Between Two Isolated Presentations of Metastatic Breast Cancer, the Second with Intracardiac Disease

Clinical breast cancer, 2006-06, Vol.7 (2), p.162-163

2006

Link zum Volltext

Verfügbarkeit prüfen

SERUM INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 FOLLOWING CHEMOTHERAPY FOR ADVANCED BREAST CANCER

ANZ journal of surgery, 2003-11, Vol.73 (11), p.905-908

2003

Link zum Volltext

Verfügbarkeit prüfen

Neratinib after adjuvant chemotherapy and trastuzumab in HER2-positive early breast cancer: Primary analysis at 2 years of a phase 3, randomized, placebo-controlled trial (ExteNET)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.508-508

2015

Link zum Volltext

Verfügbarkeit prüfen

Lack of efficacy of adjuvant lapatinib in HER2-negative breast cancer (HER2–ve BC): Analysis of patients in the TEACH trial

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.628-628

2013

Link zum Volltext

Verfügbarkeit prüfen

Subjective cognitive complaints one year after ceasing adjuvant endocrine therapy for early-stage breast cancer: Findings from the Breast International Group (BIG) 1-98 trial

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.9022-9022

2012

Link zum Volltext

Verfügbarkeit prüfen

Do men undergoing sterilizing cancer treatments have a fertile future?

Human reproduction (Oxford), 1998-11, Vol.13 (11), p.3250-3255

1998

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of the cytotoxic agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide

Cancer chemotherapy and pharmacology, 1999, Vol.44 (1), p.39-44

1999

Link zum Volltext

Verfügbarkeit prüfen

Case Reports: Late Seminomatous Relapse of a Mixed Germ Cell Tumor of the Testis on Intensive Surveillance

The Journal of urology, 1995, Vol.153 (3), p.1057-1059

1995

Link zum Volltext

Verfügbarkeit prüfen

Case Reports: Late Seminomatous Relapse of a Mixed Germ Cell Tumor of the Testis on Intensive Surveillance

The Journal of urology, 1995-03, p.1057-1059

1995

Link zum Volltext

Verfügbarkeit prüfen

The need for a national cancer control strategy in New Zealand

New Zealand medical journal, 1999-12, Vol.112 (1101), p.457-459

Cox, Brian

1999

Link zum Volltext

Verfügbarkeit prüfen

Survival of women with node negative breast cancer in the Auckland region

New Zealand medical journal, 1996-09, Vol.109 (1029), p.330

1996

Link zum Volltext

Verfügbarkeit prüfen

Evaluating and designing cancer chemotherapy treatment using mathematical models

European journal of cancer & clinical oncology, 1986, Vol.22 (1), p.3-8

1986

Link zum Volltext

Verfügbarkeit prüfen

Mitozantrone-induced onycholysis

European journal of cancer (1990), 1992, Vol.28 (1), p.243-244

1992

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of the amsacrine analogue CI-921 (NSC 343499) in non-small cell lung cancer

European journal of cancer & clinical oncology, 1991, Vol.27 (12), p.1617-1620

1991

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

Englisch
(126)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer

Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial

Bias in survival estimates created by a requirement for consent to enter a clinical breast cancer registry

Clinical behavior of recurrent hormone receptor–positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1‐98 clinical trial

CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1–98 trial

Medical resource utilization for administration of trastuzumab in a New Zealand oncology outpatient setting: a time and motion study

Overall survival from breast cancer in women pregnant or lactating at or after diagnosis

A Durable Complete Remission Between Two Isolated Presentations of Metastatic Breast Cancer, the Second with Intracardiac Disease

SERUM INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 FOLLOWING CHEMOTHERAPY FOR ADVANCED BREAST CANCER

Neratinib after adjuvant chemotherapy and trastuzumab in HER2-positive early breast cancer: Primary analysis at 2 years of a phase 3, randomized, placebo-controlled trial (ExteNET)

Lack of efficacy of adjuvant lapatinib in HER2-negative breast cancer (HER2–ve BC): Analysis of patients in the TEACH trial

Subjective cognitive complaints one year after ceasing adjuvant endocrine therapy for early-stage breast cancer: Findings from the Breast International Group (BIG) 1-98 trial

Do men undergoing sterilizing cancer treatments have a fertile future?

Phase I study of the cytotoxic agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide

Case Reports: Late Seminomatous Relapse of a Mixed Germ Cell Tumor of the Testis on Intensive Surveillance

Case Reports: Late Seminomatous Relapse of a Mixed Germ Cell Tumor of the Testis on Intensive Surveillance

The need for a national cancer control strategy in New Zealand

Survival of women with node negative breast cancer in the Auckland region

Evaluating and designing cancer chemotherapy treatment using mathematical models

Mitozantrone-induced onycholysis

Phase II study of the amsacrine analogue CI-921 (NSC 343499) in non-small cell lung cancer

Suchergebnisse filtern